Chandrasekharappa SC, Guru SC, Manickam P, Olufemi SE, Collins FS, Emmert-Buck MR, Debelenko LV, Zhuang Z, Lubensky IA, Liotta LA, et al. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science. 1997;276(5311):404–7.
Article
CAS
Google Scholar
Burgess J. How should the patient with multiple endocrine neoplasia type 1 (MEN 1) be followed? Clin Endocrinol. 2010;72(1):13–6.
Article
Google Scholar
Stratakis CA, Schussheim DH, Freedman SM, Keil MF, Pack SD, Agarwal SK, Skarulis MC, Weil RJ, Lubensky IA, Zhuang Z, et al. Pituitary macroadenoma in a 5-year-old: an early expression of multiple endocrine neoplasia type 1. J Clin Endocrinol Metab. 2000;85(12):4776–80.
CAS
PubMed
Google Scholar
Giusti F, Cianferotti L, Boaretto F, Cetani F, Cioppi F, Colao A, Davi MV, Faggiano A, Fanciulli G, Ferolla P, et al. Multiple endocrine neoplasia syndrome type 1: institution, management, and data analysis of a nationwide multicenter patient database. Endocrine. 2017;58(2):349–59.
Article
CAS
Google Scholar
Trump D, Farren B, Wooding C, Pang JT, Besser GM, Buchanan KD, Edwards CR, Heath DA, Jackson CE, Jansen S, et al. Clinical studies of multiple endocrine neoplasia type 1 (MEN1). QJM : monthly journal of the Association of Physicians. 1996;89(9):653–69.
Article
CAS
Google Scholar
Goudet P, Bonithon-Kopp C, Murat A, Ruszniewski P, Niccoli P, Menegaux F, Chabrier G, Borson-Chazot F, Tabarin A, Bouchard P, et al. Gender-related differences in MEN1 lesion occurrence and diagnosis: a cohort study of 734 cases from the Groupe d'etude des Tumeurs endocrines. Eur J Endocrinol. 2011;165(1):97–105.
Article
CAS
Google Scholar
Marini F, Falchetti A, Del Monte F, Carbonell Sala S, Gozzini A, Luzi E, Brandi ML. Multiple endocrine neoplasia type 1. Orphanet journal of rare diseases. 2006;1:38.
Article
Google Scholar
Thakker RV, Newey PJ, Walls GV, Bilezikian J, Dralle H, Ebeling PR, Melmed S, Sakurai A, Tonelli F, Brandi ML, et al. Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J Clin Endocrinol Metab. 2012;97(9):2990–3011.
Article
CAS
Google Scholar
de Laat JM, van der Luijt RB, Pieterman CR, Oostveen MP, Hermus AR, Dekkers OM, de Herder WW, van der Horst-Schrivers AN, Drent ML, Bisschop PH, et al. MEN1 redefined, a clinical comparison of mutation-positive and mutation-negative patients. BMC Med. 2016;14(1):182.
Article
Google Scholar
Ramundo V, Milone F, Severino R, Savastano S, Di Somma C, Vuolo L, De Luca L, Lombardi G, Colao A, Faggiano A: Clinical and prognostic implications of the genetic diagnosis of hereditary NET syndromes in asymptomatic patients. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 2011, 43(11):794–800.
van Leeuwaarde RS, van Nesselrooij BP, Hermus AR, Dekkers OM, de Herder WW, van der Horst-Schrivers AN, Drent ML, Bisschop PH, Havekes B, Vriens MR, et al. Impact of delay in diagnosis in outcomes in MEN1: results from the Dutch MEN1 study group. J Clin Endocrinol Metab. 2016;101(3):1159–65.
Article
Google Scholar
Gibril F, Chen YJ, Schrump DS, Vortmeyer A, Zhuang Z, Lubensky IA, Reynolds JC, Louie A, Entsuah LK, Huang K, et al. Prospective study of thymic carcinoids in patients with multiple endocrine neoplasia type 1. J Clin Endocrinol Metab. 2003;88(3):1066–81.
Article
CAS
Google Scholar
Ferolla P, Falchetti A, Filosso P, Tomassetti P, Tamburrano G, Avenia N, Daddi G, Puma F, Ribacchi R, Santeusanio F, et al. Thymic neuroendocrine carcinoma (carcinoid) in multiple endocrine neoplasia type 1 syndrome: the Italian series. J Clin Endocrinol Metab. 2005;90(5):2603–9.
Article
CAS
Google Scholar
Singh Ospina N, Thompson GB, C. Nichols F r, Cassivi SD, Young WF, Jr.: Thymic and bronchial carcinoid tumors in multiple endocrine Neoplasia type 1: the Mayo Clinic experience from 1977 to 2013. Hormones & cancer 2015, 6(5–6):247–253.
Raue F, Frank-Raue K. Update on multiple endocrine Neoplasia type 2: focus on medullary thyroid carcinoma. Journal of the Endocrine Society. 2018;2(8):933–43.
Article
CAS
Google Scholar
Goudet P, Murat A, Binquet C, Cardot-Bauters C, Costa A, Ruszniewski P, Niccoli P, Menegaux F, Chabrier G, Borson-Chazot F, et al. Risk factors and causes of death in MEN1 disease. A GTE (Groupe d'Etude des Tumeurs endocrines) cohort study among 758 patients. World J Surg. 2010;34(2):249–55.
Article
Google Scholar
de Laat JM, van Leeuwaarde RS, Valk GD. The importance of an early and accurate MEN1 diagnosis. Front Endocrinol. 2018;9:533.
Article
Google Scholar
Doherty GM, Olson JA, Frisella MM, Lairmore TC, Wells SA Jr, Norton JA. Lethality of multiple endocrine neoplasia type I. World J Surg. 1998;22(6):581–6 discussion 586-587.
Article
CAS
Google Scholar
Ito T, Igarashi H, Uehara H, Berna MJ, Jensen RT. Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1/Zollinger-Ellison syndrome patients with 1613 literature MEN1 patients with or without pancreatic endocrine tumors. Medicine. 2013;92(3):135–81.
Article
CAS
Google Scholar
Arnold PM, Floyd HE, Anderson KK, Newell KL. Surgical management of carcinoid tumors metastatic to the spine: report of three cases. Clin Neurol Neurosurg. 2010;112(5):443–5.
Article
Google Scholar
Kirkpatrick DB, Dawson E, Haskell CM, Batzdorf U. Metastatic carcinoid presenting as a spinal tumor. Surg Neurol. 1975;4(3):283–7.
CAS
PubMed
Google Scholar
Meijer WG, van der Veer E, Jager PL, van der Jagt EJ, Piers BA, Kema IP, de Vries EG, Willemse PH. Bone metastases in carcinoid tumors: clinical features, imaging characteristics, and markers of bone metabolism. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2003;44(2):184–91.
Google Scholar
Ross EM, Roberts WC. The carcinoid syndrome: comparison of 21 necropsy subjects with carcinoid heart disease to 15 necropsy subjects without carcinoid heart disease. Am J Med. 1985;79(3):339–54.
Article
CAS
Google Scholar